inv(16)(p13q22) Gbanding (left) Courtesy Jean-Luc Lai and Alain Vanderhaegen; Rbanding center bottom: Courtesy Christiane Charrin, center top and FISH (top right) -Courtesy Pascale Cornillet-Lefebvre and Stephanie Struski; FISH (bottom right) Courtesy Hossein Mossafa; commercial FISH probes, split in the inv(16). t(16;16)(p13;q22) G-banding Courtesy Diane H. Norback, Eric B. Johnson, and Sara M...

celiac disease can be accompanied with multiorgan involvement in addition to gastro-intestinal involvement. a 16-year-old young man - known case of celiac disease - was admitted because of exacerbation of gastrointestinal complaints. during further investigations, hypothyroidism and membranous glomerulonephritis were discovered. the patient was improved with a gluten-free diet and specific trea...

BACKGROUND AND OBJECTIVES This study aimed to explore the effect of functional foods on aphasia related to a previous ischemic stroke. When stroke-related neurological deficits result in physical dependency and poor selfcare that persists longer than 6 months, full recovery is almost impossible and the patient often requires long-term care. The functional foods, EASE123 and BioBalance#6, includ...

In this review ligand exchange and complex formation reactions on fac-[(CO)3M(H2O)3] (M = Mn, Tc, Re) and on fac-[(CO)2(NO)Re(H2O)3] are presented. A variety of experimental NMR techniques are described and it is shown that sometimes combinations of techniques applied at variable temperature or variable pressure allowed to measure exchange rate constants and their activation parameters as well ...

An abnormal female infant, who survived for 10 months with almost complete trisomy 16p and monosomy of sub-band 21q22.3, is described. The chromosome anomaly was the result of an unbalanced segregation of a maternal balanced translocation t(16;21)(p11;q22.3). The partial monosomy was considered to have had little or no adverse phenotypic effect. Cases with trisomy of chromosome 16 material are ...

BACKGROUND A national program for the treatment of severe allergic (IgE-dependent) asthma with omalizumab (OMA) was implemented in Poland in 2013. This observational study evaluated the effectiveness of the Polish OMA program and monitored asthma control after treatment discontinuation. METHODS In the first year of the program, 53 patients (23 new/30 continuing treatment) received OMA in the ...